AAAAAA

   
Results: 1-23 |
Results: 23
CHRONIC SYSTEMIC ASPERGILLOSIS IN A PATIENT WITH ACUTE MYELOID-LEUKEMIA
Authors: KERN W BRAESS J BERTZ H POTT C SCHLEYER E FINKE J RUCHEL R HIDDEMANN W
Citation: W. Kern et al., CHRONIC SYSTEMIC ASPERGILLOSIS IN A PATIENT WITH ACUTE MYELOID-LEUKEMIA, Annals of hematology, 76(3-4), 1998, pp. 175-177
ASPERGILLUS ANTIGEN-DETECTION - COMPARISON OF A NEW SANDWICH-ELISA WITH THE LATEX AGGLUTINATION-TEST IN PATIENTS WITH HISTOLOGICALLY PROVENINVASIVE ASPERGILLOSIS
Authors: HERRMANN J GUGEL A FREIDANK H BERTZ H FINKE J
Citation: J. Herrmann et al., ASPERGILLUS ANTIGEN-DETECTION - COMPARISON OF A NEW SANDWICH-ELISA WITH THE LATEX AGGLUTINATION-TEST IN PATIENTS WITH HISTOLOGICALLY PROVENINVASIVE ASPERGILLOSIS, Mycoses, 41, 1998, pp. 83-85
ALLOGENEIC TRANSPLANTATION OF CD34-BLOOD PROGENITOR CELLS( SELECTED OR UNSELECTED PERIPHERAL)
Authors: FINKE J BERTZ H AFTING M BEHRINGER D BERGER C HEIDECKER L KUNZMANN R MARKS R POTTHOFF K WASCH R WINKLER J MERTELSMANN R
Citation: J. Finke et al., ALLOGENEIC TRANSPLANTATION OF CD34-BLOOD PROGENITOR CELLS( SELECTED OR UNSELECTED PERIPHERAL), Bone marrow transplantation, 22, 1998, pp. 13-13
POSTTRANSPLANT MICROANGIOPATHIC HEMOLYTIC-ANEMIA (MAHA) IS ASSOCIATEDWITH ACUTE GVHD
Authors: BERTZ H EISOLD A HEIDECKER L LEIFERT J MERTELSMANN R FINKE J
Citation: H. Bertz et al., POSTTRANSPLANT MICROANGIOPATHIC HEMOLYTIC-ANEMIA (MAHA) IS ASSOCIATEDWITH ACUTE GVHD, Bone marrow transplantation, 21, 1998, pp. 422-422
SEQUENTIAL PULMONARY-FUNCTION TESTING AFTER ALLOGENEIC TRANSPLANTATION
Authors: BERTZ H SCHMOLK J KORTSIK P HEIDECKER L LEIFERT J MERTELSMANN R FINKE J
Citation: H. Bertz et al., SEQUENTIAL PULMONARY-FUNCTION TESTING AFTER ALLOGENEIC TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 567-567
HIGH-DOSE VERSUS STANDARD FILGRASTIM SIGNIFICANTLY IMPROVES MOBILIZATION OF BLOOD PROGENITORS AND FACILITATES CD34+ IMMUNOSELECTION FOR ALLOGENEIC TRANSPLANTATION
Authors: ENGELHARDT M WALLER C BERTZ H AFTING M MERTELSMANN R FINKE J
Citation: M. Engelhardt et al., HIGH-DOSE VERSUS STANDARD FILGRASTIM SIGNIFICANTLY IMPROVES MOBILIZATION OF BLOOD PROGENITORS AND FACILITATES CD34+ IMMUNOSELECTION FOR ALLOGENEIC TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 664-664
SPURIOUSLY RAISED CYCLOSPORINE CONCENTRATIONS DRAWN THROUGH POLYURETHANE CENTRAL VENOUS CATHETER
Authors: DUFFNER U BERGSTRAESSER E SAUTER S BERTZ H NIEMEYER C
Citation: U. Duffner et al., SPURIOUSLY RAISED CYCLOSPORINE CONCENTRATIONS DRAWN THROUGH POLYURETHANE CENTRAL VENOUS CATHETER, Lancet, 352(9138), 1998, pp. 1442-1442
SINUS VENOUS THROMBOSIS - AN UNUSUAL CAUSE FOR NEUROLOGIC SYMPTOMS AFTER BONE-MARROW TRANSPLANTATION UNDER IMMUNOSUPPRESSION
Authors: BERTZ H LAUBENBERGER J STEINFURTH G FINKE J
Citation: H. Bertz et al., SINUS VENOUS THROMBOSIS - AN UNUSUAL CAUSE FOR NEUROLOGIC SYMPTOMS AFTER BONE-MARROW TRANSPLANTATION UNDER IMMUNOSUPPRESSION, Transplantation, 66(2), 1998, pp. 241-244
SUCCESSFUL ADOPTIVE IMMUNOTHERAPY FOR RELAPSE OF AML 9 YEARS AFTER T-CELL-DEPLETED EMT
Authors: BERTZ H KUNZMAN R BUNJES D FINKE J
Citation: H. Bertz et al., SUCCESSFUL ADOPTIVE IMMUNOTHERAPY FOR RELAPSE OF AML 9 YEARS AFTER T-CELL-DEPLETED EMT, British Journal of Haematology, 103(2), 1998, pp. 563-564
INCIDENCE AND OUTCOME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER BLOOD ORMARROW TRANSPLANTATION - A PROSPECTIVE COHORT STUDY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION
Authors: CARRERAS E BERTZ H ARCESE W VERNANT JP TOMAS JF HAGGLUND H BANDINI G ESPEROU H RUSSELL J DELARUBIA J DIGIROLAMO G DEMUYNCK H HARTMANN O CLAUSEN J RUUTU T LEBLOND V IRIONDO A BOSI A BENBASSAT I KOZA V GRATWOHL A APPERLEY JF
Citation: E. Carreras et al., INCIDENCE AND OUTCOME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER BLOOD ORMARROW TRANSPLANTATION - A PROSPECTIVE COHORT STUDY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION, Blood, 92(10), 1998, pp. 3599-3604
ADOPTIVE IMMUNOTHERAPY FOR RELAPSED MULTIPLE-MYELOMA AFTER ALLOGENEICBONE-MARROW TRANSPLANTATION (BMT) - EVIDENCE FOR A GRAFT-VERSUS-MYELOMA EFFECT
Authors: BERTZ H BURGER JA KUNZMANN R MERTELSMANN R FINKE J
Citation: H. Bertz et al., ADOPTIVE IMMUNOTHERAPY FOR RELAPSED MULTIPLE-MYELOMA AFTER ALLOGENEICBONE-MARROW TRANSPLANTATION (BMT) - EVIDENCE FOR A GRAFT-VERSUS-MYELOMA EFFECT, Leukemia, 11(2), 1997, pp. 281-283
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR METASTATIC GASTRIC LEIOMYOSARCOMA
Authors: FETSCHER S BRUGGER W BERTZ H KRIEGER G KANZ L MERTELSMANN R LANGE W
Citation: S. Fetscher et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR METASTATIC GASTRIC LEIOMYOSARCOMA, Bone marrow transplantation, 20(9), 1997, pp. 787-788
BUSULFAN CYCLOPHOSPHAMIDE IN VOLUNTEER UNRELATED DONOR (VUD) BMT - EXCELLENT FEASIBILITY AND LOW INCIDENCE OF TREATMENT-RELATED TOXICITY/
Authors: BERTZ H POTTHOFF K MERTELSMANN R FINKE J
Citation: H. Bertz et al., BUSULFAN CYCLOPHOSPHAMIDE IN VOLUNTEER UNRELATED DONOR (VUD) BMT - EXCELLENT FEASIBILITY AND LOW INCIDENCE OF TREATMENT-RELATED TOXICITY/, Bone marrow transplantation, 19(12), 1997, pp. 1169-1173
AEROBIC EXERCISE IN THE REHABILITATION OF CANCER-PATIENTS AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS PERIPHERAL STEM-CELL TRANSPLANTATION
Authors: DIMEO FC TILMANN MHM BERTZ H KANZ L MERTELSMANN R KEUL J
Citation: Fc. Dimeo et al., AEROBIC EXERCISE IN THE REHABILITATION OF CANCER-PATIENTS AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS PERIPHERAL STEM-CELL TRANSPLANTATION, Cancer, 79(9), 1997, pp. 1717-1722
ALLOGENEIC TRANSPLANTATION FROM UNRELATED DONORS - IMPROVED OUTCOME USING IN-VIVO T-CELL DEPLETION
Authors: FINKE J BERTZ H KUNZMANN R BEHRINGER D AFTING M HEIDECKER E LANG H POTTHOFF K WASCH R MERTELSMANN R
Citation: J. Finke et al., ALLOGENEIC TRANSPLANTATION FROM UNRELATED DONORS - IMPROVED OUTCOME USING IN-VIVO T-CELL DEPLETION, Blood, 90(10), 1997, pp. 451-451
ALLOGENEIC TRANSPLANTATION OF POSITIVELY SELECTED PERIPHERAL-BLOOD CD34(+) PROGENITOR CELLS FROM MATCHED RELATED DONORS
Authors: FINKE J BRUGGER W BERTZ H BEHRINGER D KUNZMANN R WEBERNORDT RM KANZ L MERTELSMANN R
Citation: J. Finke et al., ALLOGENEIC TRANSPLANTATION OF POSITIVELY SELECTED PERIPHERAL-BLOOD CD34(+) PROGENITOR CELLS FROM MATCHED RELATED DONORS, Bone marrow transplantation, 18(6), 1996, pp. 1081-1086
AN AEROBIC EXERCISE PROGRAM FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER BONE-MARROW TRANSPLANTATION
Authors: DIMEO F BERTZ H FINKE J FETSCHER S MERTELSMANN R KEUL J
Citation: F. Dimeo et al., AN AEROBIC EXERCISE PROGRAM FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 18(6), 1996, pp. 1157-1160
MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FOR ALLOGENEIC TRANSPLANTATION - EFFICACY AND TOXICITY OF A HIGH-DOSE RHG-CSF REGIMEN
Authors: WALLER CF BERTZ H WENGER MK FETSCHER S HARDUNG M ENGELHARDT M BEHRINGER D LANGE W MERTELSMANN R FINKE J
Citation: Cf. Waller et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FOR ALLOGENEIC TRANSPLANTATION - EFFICACY AND TOXICITY OF A HIGH-DOSE RHG-CSF REGIMEN, Bone marrow transplantation, 18(2), 1996, pp. 279-283
INCIDENCE OF HEPATIC VENOOCCLUSIVE DISEASE (VOD) AFTER BMT IN EUROPE - A PROSPECTIVE COHORT STUDY OF THE EBMT
Authors: CARRERAS E BERTZ H VERNANT JP TOMAS JF HAGGLUND H BANDINI G ESPEROU H RUSELL J DELARUBIA J DIGIROLAMO G CLEEREN M HARTMANN O RUUTU T LEBLOND V IRIONDO A BOSI A BENBASSAT I KOZA V GRATWOHL A APPERLEY J
Citation: E. Carreras et al., INCIDENCE OF HEPATIC VENOOCCLUSIVE DISEASE (VOD) AFTER BMT IN EUROPE - A PROSPECTIVE COHORT STUDY OF THE EBMT, Blood, 88(10), 1996, pp. 1647-1647
COMPARISON OF IMMUNE RECONSTITUTION AND GVHD AFTER ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION WITH OR WITHOUT CD34+ SELECTION
Authors: FINKE J BEHRINGER D BERTZ H BERGER C POTTHOFF K WINKLER J HARDUNG M MERTELSMANN R
Citation: J. Finke et al., COMPARISON OF IMMUNE RECONSTITUTION AND GVHD AFTER ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION WITH OR WITHOUT CD34+ SELECTION, Blood, 88(10), 1996, pp. 2454-2454
ALLOGENETIC TRANSPLANTATION OF PERIPHERAL-BLOOD DERIVED CD34- RESULTSOF A CLINICAL PHASE-I( SELECTED PROGENITOR CELLS FROM MATCHED RELATEDDONORS )II STUDY/
Authors: FINKE J BRUGGER W BERTZ H EINSELE H BEHRINGER D KANZ L MERTELSMANN R
Citation: J. Finke et al., ALLOGENETIC TRANSPLANTATION OF PERIPHERAL-BLOOD DERIVED CD34- RESULTSOF A CLINICAL PHASE-I( SELECTED PROGENITOR CELLS FROM MATCHED RELATEDDONORS )II STUDY/, Blood, 86(10), 1995, pp. 1148-1148
RANDOMIZED PHASE-II TRIAL OF HEMATOPOIETIC GROWTH-FACTOR SUPPORT (IL-3 PLUS GM-CSF VS IL-3 PLUS G-CSF) AFTER PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN PATIENTS WITH SOLID TUMORS AND LYMPHOMAS
Authors: BRUGGER W RUMBERGER B BERTZ H FARBER L BURGER KJ MERTELSMANN R KANZ L
Citation: W. Brugger et al., RANDOMIZED PHASE-II TRIAL OF HEMATOPOIETIC GROWTH-FACTOR SUPPORT (IL-3 PLUS GM-CSF VS IL-3 PLUS G-CSF) AFTER PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN PATIENTS WITH SOLID TUMORS AND LYMPHOMAS, Blood, 84(10), 1994, pp. 10000090-10000090
PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY CHEMOTHERAPY PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR ACCELERATE BOTH NEUTROPHIL AND PLATELET RECOVERY AFTER HIGH-DOSE VP16, IFOSFAMIDE AND CISPLATIN
Authors: BRUGGER W BIRKEN R BERTZ H HECHT T PRESSLER K FRISCH J SCHULZ G MERTELSMANN R KANZ L
Citation: W. Brugger et al., PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZED BY CHEMOTHERAPY PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR ACCELERATE BOTH NEUTROPHIL AND PLATELET RECOVERY AFTER HIGH-DOSE VP16, IFOSFAMIDE AND CISPLATIN, British Journal of Haematology, 84(3), 1993, pp. 402-407
Risultati: 1-23 |